Literature DB >> 10507326

Biochemical and structural studies with neutralizing antibodies raised against foot-and-mouth disease virus.

E Domingo1, N Verdaguer, W F Ochoa, C M Ruiz-Jarabo, N Sevilla, E Baranowski, M G Mateu, I Fita.   

Abstract

The function of a loop exposed on the aphthovirus capsid (the G-H loop of protein VP1) has been explored by combining genetic and structural studies with viral mutants. The loop displays a dual function of receptor recognition and interaction with neutralizing antibodies. Remarkably, some amino acid residues play a critical role in both such disparate functions. Therefore residues subjected to antibody pressure for variation may nevertheless maintain a role in receptor recognition for which invariance is a requirement. Evolution of FMDV in cell culture may relax the requirements at this site and allow further increase of antigenic diversification. Essential residues at one stage of virus evolution may become dispensable at another not very distant point in the evolutionary landscape. Implications for FMDV evolution and vaccine design are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10507326     DOI: 10.1016/s0168-1702(99)00042-8

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  10 in total

1.  In vitro evolution and affinity-maturation with Coliphage qβ display.

Authors:  Claudia Skamel; Stephen G Aller; Alain Bopda Waffo
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

2.  Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.

Authors:  Christian D S Nelson; Laura M Palermo; Susan L Hafenstein; Colin R Parrish
Journal:  Virology       Date:  2007-01-09       Impact factor: 3.616

Review 3.  The impact of viral and host elements on HIV fitness and disease progression.

Authors:  Kenneth R Henry; Jan Weber; Miguel E Quiñones-Mateu; Eric J Arts
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

4.  Sequence conservation and antigenic variation of the structural proteins of equine rhinitis A virus.

Authors:  A Varrasso; H E Drummer; J A Huang; R A Stevenson; N Ficorilli; M J Studdert; C A Hartley
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  Xenoepitope substitution avoids deceptive imprinting and broadens the immune response to foot-and-mouth disease virus.

Authors:  Steven M Szczepanek; Roger W Barrette; Debra Rood; Diana Alejo; Lawrence K Silbart
Journal:  Clin Vaccine Immunol       Date:  2012-02-08

6.  Recovery of infectious foot-and-mouth disease virus from suckling mice after direct inoculation with in vitro-transcribed RNA.

Authors:  Eric Baranowski; Nicolás Molina; José Ignacio Núñez; Francisco Sobrino; Margarita Sáiz
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Discriminating foot-and-mouth disease virus-infected and vaccinated animals by use of beta-galactosidase allosteric biosensors.

Authors:  M Teresa Sánchez-Aparicio; María Flora Rosas; Rosa Maria Ferraz; Laura Delgui; Juan J Veloso; Esther Blanco; Antonio Villaverde; Francisco Sobrino
Journal:  Clin Vaccine Immunol       Date:  2009-06-24

8.  Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus.

Authors:  Ning-Sun Yang; Jeng-Hwan Wang; Ku-Feng Lin; Chien-Yu Wang; Suk-Am Kim; Yu-Ling Yang; Ming-Hwa Jong; Tsun-Yung Kuo; Shiow-Suey Lai; R Holland Cheng; Ming-Tsair Chan; Shu-Mei Liang
Journal:  J Gene Med       Date:  2005-06       Impact factor: 4.565

Review 9.  Foot-and-mouth disease virus evolution: exploring pathways towards virus extinction.

Authors:  E Domingo; N Pariente; A Airaksinen; C Gonzaĺez-Lopez; S Sierra; M Herrera; A Grande-Pérez; P R Lowenstein; S C Manrubia; E Lázaro; C Escarmís
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

10.  Unravelling selection shifts among foot-and-mouth disease virus (FMDV) serotypes.

Authors:  Damien C Tully; Mario A Fares
Journal:  Evol Bioinform Online       Date:  2007-02-11       Impact factor: 1.625

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.